Deka Bank Deutsche Girozentrale Acadia Pharmaceuticals Inc Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 97,284 shares of ACAD stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

97,284

Previous 97,284 -0.0%

Holding current value

$1.66 Million

Previous $1.59 Million 4.66%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$17.79 - $30.86 $48,584 - $84,278	2,731 Added 2.89%	97,284 $1.75 Million
Q4 2023 Jan 24, 2024	BUY	$20.78 - $31.77 $45,383 - $69,385	2,184 Added 2.36%	94,553 $2.93 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $49,369 - $79,290	2,369 Added 2.63%	92,369 $1.98 Million
Q2 2023 Jul 25, 2023	BUY	$17.8 - $25.65 $307,940 - $443,745	17,300 Added 23.8%	90,000 $2.14 Million
Q1 2022 Apr 28, 2022	BUY	$20.94 - $27.5 $83,760 - $110,000	4,000 Added 5.82%	72,700 $1.78 Million
Q4 2021 Feb 02, 2022	BUY	$16.79 - $27.09 $30,222 - $48,762	1,800 Added 2.69%	68,700 $1.64 Million
Q1 2021 Apr 28, 2021	BUY	$25.02 - $54.99 $65,052 - $142,974	2,600 Added 4.04%	66,900 $1.71 Million
Q4 2020 Mar 12, 2021	SELL	$41.04 - $56.79 $541,728 - $749,628	-13,200 Reduced 17.03%	64,300 $3.43 Million
Q3 2020 Oct 29, 2020	BUY	$36.42 - $57.0 $2.82 Million - $4.42 Million	77,500 New	77,500 $3.08 Million
Q4 2019 Feb 04, 2020	SELL	$36.21 - $51.4 $2.04 Million - $2.89 Million	-56,300 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $1.33 Million - $2.63 Million	-59,700 Reduced 51.47%	56,300 $2.07 Million
Q2 2019 Aug 01, 2019	BUY	$23.32 - $28.12 $985,036 - $1.19 Million	42,240 Added 57.27%	116,000 $3.07 Million
Q1 2019 May 10, 2019	BUY	$16.17 - $27.38 $198,244 - $335,678	12,260 Added 19.93%	73,760 $1.06 Million
Q4 2018 Feb 12, 2019	SELL	$14.32 - $22.92 $175,563 - $280,999	-12,260 Reduced 16.62%	61,500 $950,000
Q3 2018 Nov 09, 2018	SELL	$13.03 - $21.81 $13,942 - $23,336	-1,070 Reduced 1.43%	73,760 $0
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $212,939 - $315,664	14,130 Added 23.28%	74,830 $1.13 Million
Q1 2018 May 03, 2018	SELL	$22.47 - $32.33 $184,254 - $265,106	-8,200 Reduced 11.9%	60,700 $1.4 Million
Q3 2017 Nov 06, 2017	BUY	$29.49 - $38.37 $2.03 Million - $2.64 Million	68,900	68,900 $2.16 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Acadia Pharmaceuticals Inc Transaction History